[Clinical evaluation of antiemetic effects of 5-hydroxytryptamine receptor type 3 (5HT3 receptor) antagonists based on changes in eating condition in cancer patients receiving chemotherapy].

Source:http://linkedlifedata.com/resource/pubmed/id/18379183

Download in:

View as

General Info

PMID
18379183